• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型基于β-咔啉的异羟肟酸酯衍生物作为HDAC抑制剂的开发及其在人癌细胞中的抗增殖和抗转移活性

Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells.

作者信息

Ling Yong, Guo Jing, Yang Qiuxing, Zhu Peng, Miao Jiefei, Gao Weijie, Peng Yanfu, Yang Jiaying, Xu Kun, Xiong Biao, Liu Gongqing, Tao Jinhua, Luo Lin, Zhu Qing, Zhang Yanan

机构信息

School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong 226001, PR China; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, PR China.

School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong 226001, PR China.

出版信息

Eur J Med Chem. 2018 Jan 20;144:398-409. doi: 10.1016/j.ejmech.2017.12.061. Epub 2017 Dec 20.

DOI:10.1016/j.ejmech.2017.12.061
PMID:29288941
Abstract

A series of novel β-carboline-based hydroxamate derivatives 12a-k were designed and synthesized, and their biological activities in a series of in vitro assays were evaluated. Several of these β-carboline derivatives not only showed excellent HDAC1/3/6 inhibitory effects, but also displayed significant antitumor activities against five human cancer cells. The most potent compound 12f demonstrated the highest anticancer potency against cancer cell lines with IC values of 0.53-1.56 μM, which was considerably more potent than harmine (IC = 46.7-55.3 μM) and also three-to ten-fold lower than that of SAHA (IC = 4.48-6.26 μM). Immunoblot analysis revealed that 12f dose-dependently inhibited histone H3 and α-tubulin acetylation, confirming its HDAC inhibitory effects. Moreover, 12f significantly arrested HepG2 cells at G2/M phase through inhibiting cell cycle related protein CDK1 and cyclin B in a concentration dependent manner. Interestingly, 12f also exerted strong anti-metastasis activity by simultaneously reducing the protein level of MMP2 and MMP9 and inhibiting MAPK signaling pathway.

摘要

设计并合成了一系列新型的基于β-咔啉的异羟肟酸酯衍生物12a-k,并在一系列体外实验中评估了它们的生物活性。这些β-咔啉衍生物中的几种不仅表现出优异的HDAC1/3/6抑制作用,还对五种人类癌细胞显示出显著的抗肿瘤活性。最有效的化合物12f对癌细胞系表现出最高的抗癌效力,IC值为0.53-1.56μM,其效力远高于哈尔明(IC = 46.7-55.3μM),也比SAHA(IC = 4.48-6.26μM)低三到十倍。免疫印迹分析表明,12f剂量依赖性地抑制组蛋白H3和α-微管蛋白的乙酰化,证实了其HDAC抑制作用。此外,12f通过浓度依赖性地抑制细胞周期相关蛋白CDK1和细胞周期蛋白B,使HepG2细胞在G2/M期显著停滞。有趣的是,12f还通过同时降低MMP2和MMP9的蛋白水平并抑制MAPK信号通路发挥强大的抗转移活性。

相似文献

1
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells.新型基于β-咔啉的异羟肟酸酯衍生物作为HDAC抑制剂的开发及其在人癌细胞中的抗增殖和抗转移活性
Eur J Med Chem. 2018 Jan 20;144:398-409. doi: 10.1016/j.ejmech.2017.12.061. Epub 2017 Dec 20.
2
Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.含1,2,4-恶二唑部分的2-氨基苯甲酰胺和异羟肟酸酯衍生物作为有效的组蛋白脱乙酰酶抑制剂的发现及初步评价
Eur J Med Chem. 2015;96:1-13. doi: 10.1016/j.ejmech.2015.04.002. Epub 2015 Apr 6.
3
Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.新型羟肟酸和 2-氨基苯甲酰胺类化合物的设计、合成及作为有效的组蛋白去乙酰化酶抑制剂和抗肿瘤剂的生物评价。
Eur J Med Chem. 2017 Jul 7;134:1-12. doi: 10.1016/j.ejmech.2017.03.038. Epub 2017 Mar 22.
4
Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities.新型香豆素类羟肟酸衍生物的设计、合成及作为具有抗肿瘤活性的组蛋白去乙酰化酶(HDAC)抑制剂的生物评价。
Molecules. 2019 Jul 15;24(14):2569. doi: 10.3390/molecules24142569.
5
Design and synthesis of a new generation of substituted purine hydroxamate analogs as histone deacetylase inhibitors.新一代取代嘌呤异羟肟酸酯类似物作为组蛋白脱乙酰酶抑制剂的设计与合成
Bioorg Med Chem. 2016 Apr 1;24(7):1446-54. doi: 10.1016/j.bmc.2016.02.005. Epub 2016 Feb 6.
6
β-Carboline tethered cinnamoyl 2-aminobenzamides as class I selective HDAC inhibitors: Design, synthesis, biological activities and modelling studies.β-咔啉连接肉桂酰基 2-氨基苯甲酰胺作为 I 类选择性组蛋白去乙酰化酶抑制剂:设计、合成、生物活性和建模研究。
Bioorg Chem. 2021 Dec;117:105461. doi: 10.1016/j.bioorg.2021.105461. Epub 2021 Oct 31.
7
A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects.一种新型的 harmine 衍生物,N-(4-(羟氨基甲酰基)苄基)-1-(4-甲氧基苯基)-9H-吡啶并[3,4-b]吲哚-3-甲酰胺(HBC),作为组蛋白去乙酰化酶抑制剂:体外抗增殖、凋亡诱导、细胞周期阻滞和抗转移作用。
Eur J Pharmacol. 2018 Apr 5;824:78-88. doi: 10.1016/j.ejphar.2018.02.004. Epub 2018 Feb 9.
8
Hydroxamic Acid Derivatives of β-Carboline/Hydroxycinnamic Acid Hybrids Inducing Apoptosis and Autophagy through the PI3K/Akt/mTOR Pathways.β-咔啉/羟基肉桂酸杂合的羟肟酸衍生物通过 PI3K/Akt/mTOR 通路诱导细胞凋亡和自噬。
J Nat Prod. 2019 Jun 28;82(6):1442-1450. doi: 10.1021/acs.jnatprod.8b00843. Epub 2019 May 23.
9
A hybrid of thiazolidinone with the hydroxamate scaffold for developing novel histone deacetylase inhibitors with antitumor activities.一种噻唑烷酮与异羟肟酸支架的杂合物,用于开发具有抗肿瘤活性的新型组蛋白脱乙酰酶抑制剂。
Org Biomol Chem. 2016 Feb 7;14(5):1727-35. doi: 10.1039/c5ob02250a.
10
Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitors.基于吲哚的羟肟酸衍生物的设计、合成及作为组蛋白去乙酰化酶抑制剂的生物评价。
Eur J Med Chem. 2022 Jan 5;227:113893. doi: 10.1016/j.ejmech.2021.113893. Epub 2021 Oct 2.

引用本文的文献

1
Tryptophan metabolite norharman secreted by cultivated Lactobacillus attenuates acute pancreatitis as an antagonist of histone deacetylases.色氨酸代谢产物降哈尔曼经体外培养的嗜酸乳杆菌分泌后,作为组蛋白去乙酰化酶的拮抗剂,可减轻急性胰腺炎。
BMC Med. 2023 Aug 28;21(1):329. doi: 10.1186/s12916-023-02997-2.
2
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids.杂合药物的概念及抗癌杂合体的最新进展
Pharmaceuticals (Basel). 2022 Aug 28;15(9):1071. doi: 10.3390/ph15091071.
3
A "Double-Locked" and Enzyme/pH-Activated Theranostic Agent for Accurate Tumor Imaging and Therapy.
一种“双重锁定”且酶/ pH 激活的治疗诊断试剂,可实现精确的肿瘤成像和治疗。
Molecules. 2022 Jan 10;27(2):425. doi: 10.3390/molecules27020425.
4
Synthesis and Biological Evaluation of Harmirins, Novel Harmine-Coumarin Hybrids as Potential Anticancer Agents.合成与生物评价的 Harmirins,新型哈尔明-香豆素杂合体作为潜在的抗癌药物。
Molecules. 2021 Oct 27;26(21):6490. doi: 10.3390/molecules26216490.
5
β-Carboline-based molecular hybrids as anticancer agents: a brief sketch.基于β-咔啉的分子杂化物作为抗癌剂:简要概述。
RSC Med Chem. 2021 Mar 24;12(5):730-750. doi: 10.1039/d0md00422g. eCollection 2021 May 26.
6
Design, synthesis and biological evaluation of a series of CNS penetrant HDAC inhibitors structurally derived from amyloid-β probes.设计、合成及一系列中枢神经系统穿透性 HDAC 抑制剂的生物评价,该抑制剂结构来源于淀粉样β探针。
Sci Rep. 2019 Sep 12;9(1):13187. doi: 10.1038/s41598-019-49784-9.
7
Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent β-Carbolines as Potential Anticancer Agents.新型 N-酰腙键连接的杂双β-咔啉类化合物的设计、合成及生物评价作为潜在的抗癌剂。
Molecules. 2019 Aug 14;24(16):2950. doi: 10.3390/molecules24162950.
8
BCESA: a nano-scaled intercalator capable of targeting tumor tissue and releasing anti-tumoral β-carboline-3-carboxylic acid.BCESA:一种纳米级的嵌入剂,能够靶向肿瘤组织并释放抗肿瘤 β-咔啉-3-羧酸。
Int J Nanomedicine. 2019 Apr 30;14:3027-3041. doi: 10.2147/IJN.S187600. eCollection 2019.